Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections

Journal of Clinical Investigation

Volumn 127, Issue 9, 2017, Pages 3543-3556

  Ogunjimi, Benson ^a,b,c,d   Zhang, Shen Ying ^e,f,g   Sorensen, Katrine B ^h,i   Skipper, Kristian A ⁱ   Carter Timofte, Madalina ^h,i   Kerner, Gaspard ^f,g   Luecke, Stefanie ⁱ   Prabakaran, Thaneas ⁱ   Cai, Yujia ⁱ   Meester, Josephina ^b   Bartholomeus, Esther ^b   Bolar, Nikhita Ajit ^b   Vandeweyer, Geert ^b   Claes, Charlotte ^b   Sillis, Yasmine ^b   Lorenzo, Lazaro ^e,f,g   Fiorenza, Raffaele A ^e,f,g   Boucherit, Soraya ^e,f,g   Dielman, Charlotte ^j   Heynderickx, Steven ^a   Elias, George ^a   Kurotova, Andrea ^k   Auwera, Ann Vander ^l   Verstraete, Lieve ^m   Lagae, Lieven ⁿ   Verhelst, Helene ^c   Jansen, Anna ^o,p   Ramet, Jose ^b   Suls, Arvid ^b   Smits, Evelien ^a   Ceulemans, Berten ^b   Laer, Lut Van ^b   Wilson, Genevieve Plat ^q   Kreth, Jonas ^r   Picard, Capucine ^f,g   Bernuth, Horst Von ^s   Fluss, Joel ^t   Chabrier, Stephane ^u   Abel, Laurent ^e,f,g   Mortier, Geert ^b   Fribourg, Sebastien ^v   Mikkelsen, Jacob Giehm ⁱ   Casanova, Jean Laurent ^e,f,g,w,x   Paludan, Soren R ⁱ   Mogensen, Trine H ^h,i   more..

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing   (Belgium)

^e ROCKEFELLER UNIVERSITY   (United States)

^f IMAGINE INSTITUTE   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁱ AARHUS UNIVERSITY   (Denmark)

^j Queen Paola Children's Hospital   (Belgium)

^k Sint Vincentiusziekenhuis   (Belgium)

^l SINT AUGUSTINUS HOSPITAL   (Belgium)

^m Department of Radiology   (Belgium)

ⁿ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^o UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^p VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^q TOULOUSE UNIVERSITY HOSPITAL   (France)

^r KLINIKUM LEVERKUSEN   (Germany)

^s CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^t Children's Hospital of Geneva   (Switzerland)

^u UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^v INSERM U869   (France)

^w HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^x HÔPITAL NECKER ENFANTS MALADES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; INTERFERON; VIRUS DNA;

ALLELE; ARTICLE; CENTRAL NERVOUS SYSTEM; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; GENE; HERPES ZOSTER; HUMAN; HUMAN CELL; LEUKOCYTE; LUNG; MISSENSE MUTATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POLR3A GENE; POLR3C GENE; PRIORITY JOURNAL; ANIMAL; CHICKENPOX; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HETEROZYGOTE; METABOLISM; MOUSE; MUTATION; VARICELLA ZOSTER VIRUS;

ALLELES; ANIMALS; CHICKENPOX; CHILD; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEK293 CELLS; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HETEROZYGOTE; HUMANS; LEUKOCYTES; MICE; MUTATION; MUTATION, MISSENSE; PHENOTYPE; RNA POLYMERASE III;

EID: 85028938708     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI92280     Document Type: Article

References (46)

1. Arvin AM, Gilden D. Varicella-zoster virus. In: Knipe DM, Howley P, eds. Fields Virology. Philadelphia, Pennsylvania, USA: Lippincott Williams & Wilkins;2015: 2015-2057.
2. Zerboni L, Sen N, Oliver SL, Arvin AM. Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol. 2014;12(3):197-210.
3. Whitley RJ. Chickenpox and herpes zoster (varicella-zoster virus). In: Bennet J, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Amsterdam, Netherlands: Elsevier; 2014: 1731-1737.
4. Gershon AA, Gershon MD. Perspectives on vaccines against varicella-zoster virus infections. Curr Top Microbiol Immunol. 2010;342:359-372.
5. Breuer J. VZV molecular epidemiology. Curr Top Microbiol Immunol. 2010;342:15-42.
6. Wiegering V, et al. Varicella-zoster virus infections in immunocompromised patients-A single centre 6-years analysis. BMC Pediatr. 2011;11:31.
7. Brooks EG, et al. A novel X-linked combined immunodeficiency disease. J Clin Invest. 1990;86(5):1623-1631.
8. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med. 1989;320(26):1731-1735.
9. Hsu AP, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653-2655.
10. Dobbs K, et al. Inherited DOCK2 deficiency in patients with early-onset invasive infections. N Engl J Med. 2015;372(25):2409-2422.
11. Zhang Q, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361(21):2046-2055.
12. Roesler J, et al. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp Hematol. 1999;27(9):1368-1374.
13. Kreins AY, et al. Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome. J Exp Med. 2015;212(10):1641-1662.
14. Mace EM, et al. Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. Blood. 2013;121(14):2669-2677.
15. Casanova JL. Human genetic basis of interindividual variability in the course of infection. Proc Natl Acad Sci U S A. 2015;112(51):E7118-E7127.
16. Casanova JL. Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc Natl Acad Sci U S A. 2015;112(51):E7128-E7137.
17. Zhang SY, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007;317(5844):1522-1527.
18. Sancho-Shimizu V, et al. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest. 2011;121(12):4889-4902.
19. Perez de Diego R, et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity. 2010;33(3):400-411.
20. Herman M, et al. Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J Exp Med. 2012;209(9):1567-1582.
21. Audry M, et al. NEMO is a key component of NF-κB-and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus. J Allergy Clin Immunol. 2011;128(3):610-617.e1.
22. Andersen LL, et al. Functional IRF3 deficiency in a patient with herpes simplex encephalitis. J Exp Med. 2015;212(9):1371-1379.
23. Lim HK, et al. TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk. Neurology. 2014;83(21):1888-1897.
24. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009;22(2):240-273.
25. Hemmi H, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408(6813):740-745.
26. Chiu YH, Macmillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell. 2009;138(3):576-591.
27. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol. 2009;10(10):1065-1072.
28. Unterholzner L, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol. 2010;11(11):997-1004.
29. Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMPAMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339(6121):786-791.
30. Hoffmann NA, et al. Molecular structures of unbound and transcribing RNA polymerase III. Nature. 2015;528(7581):231-236.
31. Lefevre S, et al. Structure-function analysis of hRPC62 provides insights into RNA polymerase III transcription initiation. Nat Struct Mol Biol. 2011;18(3):352-358.
32. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310-315.
33. Itan Y, et al. The mutation significance cutoff: gene-level thresholds for variant predictions. Nat Methods. 2016;13(2):109-110.
34. Itan Y, et al. The human gene damage index as a gene-level approach to prioritizing exome variants. Proc Natl Acad Sci U S A. 2015;112(44):13615-13620.
35. Yoneyama M, et al. The RNA helicase RIG-I has an essential function in double-stranded RNAinduced innate antiviral responses. Nat Immunol. 2004;5(7):730-737.
36. Nagel MA, Choe A, Traktinskiy I, Cordery-Cotter R, Gilden D, Cohrs RJ. Varicella-zoster virus transcriptome in latently infected human ganglia. J Virol. 2011;85(5):2276-2287.
37. Wang Z, Roeder RG. Three human RNA polymerase III-specific subunits form a subcomplex with a selective function in specific transcription initiation. Genes Dev. 1997;11(10):1315-1326.
38. Bernard G, et al. Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am J Hum Genet. 2011;89(3):415-423.
39. Tetreault M, et al. Recessive mutations in POLR3B, encoding the second largest subunit of Pol III, cause a rare hypomyelinating leukodystrophy. Am J Hum Genet. 2011;89(5):652-655.
40. Saitsu H, et al. Mutations in POLR3A and POLR3B encoding RNA Polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. Am J Hum Genet. 2011;89(5):644-651.
41. Li XD, Wu J, Gao D, Wang H, Sun L, Chen ZJ. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science. 2013;341(6152):1390-1394.
42. Schoggins JW, et al. Pan-viral specificity of IFNinduced genes reveals new roles for cGAS in innate immunity. Nature. 2014;505(7485):691-695.
43. Ku CC, Zerboni L, Ito H, Graham BS, Wallace M, Arvin AM. Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med. 2004;200(7):917-925.
44. James SH, Kimberlin DW, Whitley RJ. Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res. 2009;83(3):207-213.
45. Kragballe K, Desjarlais L, Marcelo CL. Increased DNA synthesis of uninvolved psoriatic epidermis is maintained in vitro. Br J Dermatol. 1985;112(3):263-270.
46. Jakobsen M, et al. Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation model. Mol Ther. 2009;17(10):1743-1753.